CLL / SLL PATIENT EDUCATION ToolKIT
Understand the disease, treatment, and essential health information.
LEARN MORE »
CLL / SLL PATIENT EDUCATION ToolKIT
Understand the disease, treatment, and essential health information.
LEARN MORE »

WELCOME

CLL Society is the world’s leading authority for chronic lymphocytic leukemia and small lymphocytic lymphoma cancer patients. We are devoted to serving our community through CLL and SLL education, support, advocacy and research.
Newly Diagnosed? Click below for helpful resources:

Actively Enrolling Clinical Trials in CLL

An investigational CAR-T option

An investigational JCAR017 trial in CLL that failed BTKi and BCL2i therapies

Currently enrolling participants with double-class exposed CLL

A phase 2 study with investigational BTK inhibitor-based regimens for participants with CLL

Currently enrolling participants with previously untreated CLL / SLL

An investigational CAR-T option

An investigational JCAR017 trial in CLL that failed BTKi and BCL2i therapies

Currently enrolling participants with double-class exposed CLL

A clinical study for BTK inhibitors resistance

Docirbrutinib: an Investigational Oral BTK Inhibitor

Currently enrolling participants with CLL / SLL and B-cell NHL

A Study of an Investigational Agent in Mature B-Cell Malignancies

Currently enrolling participants.

Access additional information about clinical trials:
https://cllsociety.org/treatment-and-research/clinical-trials/

Support Our Work

Everyone diagnosed with chronic lymphocytic leukemia (CLL) deserves quality care and support for their cancer. CLL Society is here to provide education and support to ensure no one goes through the journey alone.

Fast Find

One click to our most popular content.

Newly Diagnosed

Testing & Imaging

Treatment & Research

Support
Groups

Stories and Testimonials

Free CLL
Expert Opinion

Normal Lab Values & Tracker

Ask the
Experts

Thank You.

CLL Society 2025 Industry Advisory Council

platinum

Gold

Silver